Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 2,000 shares at $34.96 ($66K) on 2015-09-16, disclosed to the SEC on 2015-09-18.
Scheduled sale ($66k) by EVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.22 | 1,100 | $35K | 53.3% |
| 2 | $33.55 | 300 | $10K | 15.1% |
| 3 | $34.93 | 200 | $7K | 10.5% |
| 4 | $34.96 | 400 | $14K | 21.0% |
| Total | $33.24 avg | 2,000 | $66K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |